Tilray Medical Granted Approval to Introduce Third Medical Cannabis Product in Portugal
Tilray Medical receives second approval for new medical cannabis extract in Portugal: Tilray Oral Solution THC10:CBD10 or Tilray Solução Oral THC10:CBD10.
CANTANHEDE, Portugal, July 24, 2024 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (Tilray) (Nasdaq: TLRY; TSX: TLRY), a global leader in cannabis research, cultivation, production, and distribution, today …